Compare STXS & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STXS | MED |
|---|---|---|
| Founded | 1990 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 120.6M |
| IPO Year | 2004 | N/A |
| Metric | STXS | MED |
|---|---|---|
| Price | $2.43 | $11.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $4.00 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 415.9K | 279.0K |
| Earning Date | 11-11-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | $30,075,000.00 | ★ $429,695,000.00 |
| Revenue This Year | $24.21 | N/A |
| Revenue Next Year | $29.83 | N/A |
| P/E Ratio | ★ N/A | $467.45 |
| Revenue Growth | ★ 19.62 | N/A |
| 52 Week Low | $1.54 | $10.36 |
| 52 Week High | $3.59 | $18.59 |
| Indicator | STXS | MED |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 44.67 |
| Support Level | $2.30 | $11.07 |
| Resistance Level | $2.54 | $12.40 |
| Average True Range (ATR) | 0.09 | 0.42 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 53.39 | 29.17 |
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.